174709-30-9Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21YAMAGACQNDAKFB-UHFFFAOYSA-N174709-30-9DTXSID60274366CHEMBL174426DescriptionBPIQ-I is a quinazoline that inhibits the tyrosine kinase activity of the epidermal growth factor receptor (IC50 = 0.025 nM). It can inhibit the growth of SKOV3 and MDA-468 tumor cell lines with EC50 values of 6.5 and 30 μM, respectively.
UsesBPIQ-I (PD 159121) is a potent and ATP-competitive EGFR tyrosine kinase inhibitor.. BPIQ-I shows anti-proliferative actively[1][2].
No reaction records under the current filter.
Loading…